Total planned funding: $610,101,711
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $610,101,711 |
Organizational Types
NGO | $154,440,466 |
Private Contractor | $139,969,344 |
Own Agency | $93,426,744 |
Host Country Government Agency | $71,475,677 |
University | $65,338,460 |
Unknown | $55,553,675 |
Parastatal | $12,961,686 |
Other USG Agency | $7,402,083 |
Implementing Agency | $5,249,818 |
Multi-lateral Agency | $2,723,758 |
FBO | $1,560,000 |
Program Areas
Treatment | $183,731,079 |
Prevention | $127,254,508 |
Care | $123,101,149 |
Governance and Systems | $77,176,542 |
Management and Operations | $56,506,757 |
Testing | $42,331,676 |
Budget Codes
HTXS: Treatment: Adult Treatment | $153,302,657 |
HVMS: Management and Operations | $56,506,757 |
HKID: Care: Orphans and Vulnerable Children | $54,607,443 |
HVCT: Testing: HIV Testing and Counseling | $42,331,676 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $41,588,481 |
HBHC: Care: Adult Care and Support | $36,472,360 |
HVOP: Sexual Prevention: Other Sexual Prevention | $35,294,185 |
OHSS: Health Systems Strengthening | $34,580,904 |
HVSI: Strategic Information | $31,462,237 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $23,221,621 |
HVTB: Care: TB/HIV | $21,240,458 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,766,325 |
HTXD: Treatment: ARV Drugs | $16,167,563 |
PDTX: Treatment: Pediatric Treatment | $14,260,859 |
HLAB: Laboratory Infrastructure | $11,133,401 |
PDCS: Care: Pediatric Care and Support | $10,780,888 |
HMBL: Biomedical Prevention: Blood Safety | $6,276,440 |
HMIN: Biomedical Prevention: Injection Safety | $3,107,456 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$76,285,426
Countries/Regions
University of Washington:
$49,763,395
Countries/Regions
USG Aggregated Agencies:
$45,214,791
Countries/Regions